US · OCSL · ASSET MANAGEMENT
Oaktree Specialty Lending Corporation (OCSL) intrinsic value and stock valuation
$11.72as of 2026-11-21 · Mkt cap 1.06B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Oaktree Specialty Lending Corporation DCF and intrinsic value
InvestorsCraft values OCSL with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from OCSL’s statements →
Oaktree Specialty Lending Corporation Graham Number
Graham Number: $12.29d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $299.7M | $186.2M | $236.9M | $86M | $278.8M |
| Operating income | $151M | $57.8M | $119.1M | $32.9M | $240.8M |
| Net income | $33.9M | $57.9M | $117.3M | $29.2M | $237.3M |
| EPSd | $394.1K | $720.1K | $1.63M | $481.1K | $4.39M |
| Operating cash flow | $142.4M | $19.1M | $228.8M | $22.4M | -$-230.52M |
| Capital expenditure | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Free cash flow | $142.4M | $19.1M | $228.8M | $22.4M | -$-230.52M |
| Total assets | $3B | $3.2B | $3.22B | $2.65B | $2.64B |
| Total debt | $1.49B | $1.64B | $1.6B | $1.3B | $1.27B |
| Net debt | $1.41B | $1.57B | $1.46B | $1.28B | $1.24B |
| Total equity | $1.47B | $1.49B | $1.52B | $1.25B | $1.31B |
| Cash and short-term investments | $79.6M | $64M | $136.5M | $23.5M | $29.3M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $299.7M | $186.2M | $236.9M | $86M | $278.8M |
| Cost of revenue | $38.3M | $128.6M | $111.6M | $46.9M | $30.5M |
| Gross profit | $261.4M | $57.6M | $125.2M | $39.1M | $248.3M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $8.48M | $9.5M | $11.7M | $9.25M | $9.07M |
| Other expenses | $101.9M | -$-9.69M | -$-5.53M | -$-3M | -$-1.61M |
| Operating expenses | $110.4M | -$-180K | $6.14M | $6.25M | $7.46M |
| Cost and expenses | $148.7M | $128.4M | $117.8M | $53.2M | $38M |
| Interest income | $307.5M | $367.1M | $368.5M | $249.4M | $190.8M |
| Interest expense | $115.8M | $128.6M | $111.6M | $46.9M | $30.5M |
| Depreciation and amortization | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ebitda | $151M | $57.8M | $119.1M | $32.9M | $240.8M |
| Operating income | $151M | $57.8M | $119.1M | $32.9M | $240.8M |
| Total other income/expenses, net | -$-115.84M | $0.00 | $0.00 | $0.00 | $0.00 |
| Income before tax | $35.2M | $57.8M | $119.1M | $32.9M | $240.8M |
| Income tax expense | $1.25M | -$-110K | $1.73M | $3.64M | $3.58M |
| Net income | $33.9M | $57.9M | $117.3M | $29.2M | $237.3M |
| Weighted average shares outstanding | $86.1M | $80.4M | $72.1M | $60.7M | $54M |
| Weighted average diluted shares outstanding | $86.1M | $80.4M | $72.1M | $60.7M | $54M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $79.6M | $64M | $136.5M | $23.5M | $29.3M |
| Net receivables | $55.6M | $85.9M | $160.6M | $108.3M | $33.9M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $135.2M | $149.9M | $297M | $131.8M | $63.2M |
| Property, plant and equipment, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill and intangible assets | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Long-term investments | $8.71M | $0.00 | $4.91M | $6.79M | $1.91M |
| Total non-current assets | $2.87B | $3.05B | $2.92B | $2.51B | $2.57B |
| Total assets | $3B | $3.2B | $3.22B | $2.65B | $2.64B |
| Accounts payable | $12.1M | $16.2M | $16M | $7.94M | $4.6M |
| Short-term debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $12.1M | $16.2M | $16M | $7.94M | $4.6M |
| Long-term debt | $1.49B | $1.64B | $1.6B | $1.3B | $1.27B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $1.53B | $1.69B | $1.69B | $1.39B | $1.32B |
| Capital lease obligations | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total liabilities | $1.54B | $1.71B | $1.7B | $1.4B | $1.32B |
| Common stock | $880K | $820K | $770K | $610K | $1.8M |
| Retained earnings | -$-885.14M | -$-777.46M | -$-651.34M | -$-582.77M | -$-493.33M |
| Accumulated other comprehensive income (loss) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total equity | $1.47B | $1.49B | $1.52B | $1.25B | $1.31B |
| Total investments | $8.71M | $0.00 | $4.91M | $6.79M | $1.91M |
| Total debt | $1.49B | $1.64B | $1.6B | $1.3B | $1.27B |
| Net debt | $1.41B | $1.57B | $1.46B | $1.28B | $1.24B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $33.9M | $57.9M | $117.3M | $29.2M | $237.3M |
| Depreciation and amortization | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | $17.5M | $71.6M | -$-107.4M | -$-71.41M | $21.2M |
| Accounts receivable | $29M | $70.5M | -$-42.61M | -$-77.05M | -$-6.26M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | -$-3.45M | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash provided by operating activities | $142.4M | $19.1M | $228.8M | $22.4M | -$-230.52M |
| Investments in property, plant and equipment | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acquisitions, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | $86M | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock issued | $103M | $92.8M | $1.37M | $20.8M | $0.00 |
| Common stock repurchased | -$-10.67M | -$-1.55M | -$-2.42M | -$-1.86M | -$-2.17M |
| Dividends paid | -$-148.2M | -$-176.81M | -$-180.05M | -$-115.25M | -$-79.85M |
| Net cash used for financing activities | -$-229.35M | -$-86.77M | -$-110.41M | -$-26.82M | $224.2M |
| Net change in cash | $1.09M | -$-67M | $119.2M | -$-5.27M | -$-7.46M |
| Cash at end of period | $79.6M | $78.5M | $145.5M | $26.4M | $31.6M |
| Operating cash flow | $142.4M | $19.1M | $228.8M | $22.4M | -$-230.52M |
| Capital expenditure | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Free cash flow | $142.4M | $19.1M | $228.8M | $22.4M | -$-230.52M |
Line items
Line items
Line items
About Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corporation (OCSL) functions as a business development company (BDC), dedicated to providing capital solutions for middle-market businesses. Its investment strategy involves a diverse array of financing types, including interim bridge loans, various tiers of secured debt (first and second lien, senior and junior), unsecured loans, hybrid mezzanine debt, and preferred equity stakes. These funds are primarily deployed to support growth initiatives such as corporate expansions, acquisitions led by private equity sponsors, and management buyouts within small and mid-sized enterprises. OCSL actively seeks opportunities across a broad spectrum of industries, including education, general business services, retail and consumer products, healthcare, manufacturing, the food and restaurant sector, construction and engineering, and media and advertising. Individual investments typically range from $5 million to $75 million, predominantly structured as integrated ("one-stop"), first-lien, or second-lien debt facilities, with the potential for a complementary equity co-investment. The target companies generally possess an enterprise value between $20 million and $150 million, and generate operating cash flow (EBITDA) of $3 million to $50 million. While the fund can commit up to $75 million per investment, it has the capacity to originate and underwrite larger transactions, up to $100 million. OCSL primarily concentrates its investment activities within the North American market and aims to serve as the lead investor in its portfolio companies.
- CEO
- Armen Panossian
- Employees
- 0
- Beta
- 0.57
Explore
Frequently asked questions
What is the intrinsic value of Oaktree Specialty Lending Corporation (OCSL)?
Oaktree Specialty Lending Corporation (OCSL) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is OCSL undervalued?
OCSL trades at a price of $11.72 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.